Antirheumatic Drugs against COVID-19 from the Perspective of Rheumatologists
Review
[키워드] activate
anti-IL-1
Antigen
antirheumatic
Antirheumatic drugs
Baricitinib
blockade
Chloroquine
clinical impact
Colchicine
Coronavirus disease 2019
Course
COVID-19
cytokine
Cytokine storm
Disease progression
Diseases
drug
drugs
effective
expected
Glucocorticoids
Hydroxychloroquine
Immune cell
immunomodulatory
immunosuppressants
immunosuppressive drug
Immunosuppressive treatment
Inflammatory cytokines
inhibitor
inhibitors
Janus kinase inhibitor
management
mechanism
mechanism of action
Necrosis
pandemic
Pathogenesis
pathophysiology
patient death
prevent disease progression
Rheumatic diseases
sarilumab
SARS-CoV-2
Stage
the cytokine storm
the disease
Tocilizumab
Tofacitinib
treatment for COVID-19
viral replication
[DOI] 10.3390/ph14121256 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/ph14121256 PMC 바로가기 [Article Type] Review